Corient Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.56M | Buy |
|
|||||
|
2022
Q2 | $1.45M | Buy |
|
|||||
|
2022
Q1 | $1.11M | Sell |
|
|||||
|
2021
Q4 | $1.42M | Buy |
|
|||||
|
2021
Q3 | $1.34M | Buy |
|
|||||
|
2021
Q2 | $1.31M | Buy |
|
|||||
|
2021
Q1 | $1.11M | Buy |
|
|||||
|
2020
Q4 | $663K | Sell |
|
|||||
|
2020
Q3 | $976K | Sell |
|
|||||
|
2020
Q2 | $1.57M | Buy |
|
|||||
|
2020
Q1 | $1.08M | Buy |
|
|||||
|
2019
Q4 | $739K | Buy |
|
|||||
|
2019
Q3 | $667K | Sell |
|
|||||
|
2019
Q2 | $738K | Buy |
|
|||||
|
2019
Q1 | $471K | Sell |
|
|||||
|
2018
Q4 | $1.88M | Sell |
|
|||||
|
2018
Q3 | $3.25M | Hold |
|
|||||
|
2018
Q2 | $2.98M | Buy |
|
|||||
|
2018
Q1 | $2.73M | Buy |
|
|||||
|
2017
Q4 | $1.39M | Sell |
|
|||||
|
2017
Q3 | $2.74M | Sell |
|
|||||
|
2017
Q2 | $3.11M | Sell |
|
|||||
|
2017
Q1 | $3.03M | Sell |
|
|||||
|
2016
Q4 | $3.24M | Buy |
|
|||||
|
2016
Q3 | $2.39M | Buy |
|